CVS Health Corporation $CVS Shares Sold by Thompson Investment Management Inc.

Key Points

• Thompson Investment Management Inc. reduced its stake in CVS Health by 11.9%, now holding 125,372 shares valued at approximately $8.65 million.
• CVS Health's stock has received positive ratings from multiple analysts, with price targets raised up to $87.00 and a consensus rating of "Moderate Buy."
• The company announced a quarterly dividend of $0.665 per share, representing a 3.5% yield and a payout ratio of 74.30%.

Thompson Investment Management Inc. cut its stake in shares of CVS Health Corporation (NYSE:CVS - Free Report) by 11.9% during the 2nd quarter, according to its most recent filing with the SEC. The institutional investor owned 125,372 shares of the pharmacy operator's stock after selling 16,889 shares during the period. CVS Health makes up approximately 1.2% of Thompson Investment Management Inc.'s holdings, making the stock its 27th largest holding. Thompson Investment Management Inc.'s holdings in CVS Health were worth $8,648,000 at the end of the most recent reporting period.

Several other large investors also recently bought and sold shares of the company. Vanguard Group Inc. lifted its stake in CVS Health by 0.8% during the first quarter. Vanguard Group Inc. now owns 118,335,394 shares of the pharmacy operator's stock worth $8,017,223,000 after purchasing an additional 969,027 shares during the last quarter. Dodge & Cox raised its holdings in CVS Health by 4.8% during the first quarter. Dodge & Cox now owns 73,459,122 shares of the pharmacy operator's stock worth $4,976,856,000 after purchasing an additional 3,353,223 shares in the last quarter. Invesco Ltd. lifted its position in CVS Health by 13.2% in the first quarter. Invesco Ltd. now owns 20,413,853 shares of the pharmacy operator's stock worth $1,383,039,000 after purchasing an additional 2,375,764 shares during the period. Price T Rowe Associates Inc. MD increased its position in shares of CVS Health by 14.5% during the 1st quarter. Price T Rowe Associates Inc. MD now owns 15,309,289 shares of the pharmacy operator's stock valued at $1,037,205,000 after purchasing an additional 1,942,886 shares during the period. Finally, Charles Schwab Investment Management Inc. lifted its holdings in shares of CVS Health by 5.6% in the first quarter. Charles Schwab Investment Management Inc. now owns 13,647,873 shares of the pharmacy operator's stock valued at $924,643,000 after buying an additional 728,924 shares during the period. Institutional investors and hedge funds own 80.66% of the company's stock.

Insiders Place Their Bets

In other CVS Health news, Director Anne A. Finucane sold 7,500 shares of the firm's stock in a transaction that occurred on Wednesday, August 20th. The stock was sold at an average price of $71.02, for a total value of $532,650.00. Following the sale, the director owned 22,156 shares of the company's stock, valued at $1,573,519.12. This trade represents a 25.29% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available through this link. 1.22% of the stock is currently owned by insiders.

Analysts Set New Price Targets

Several equities research analysts have recently weighed in on the company. Robert W. Baird raised CVS Health from a "neutral" rating to an "outperform" rating and raised their price objective for the stock from $71.00 to $82.00 in a research note on Thursday, August 14th. Baird R W raised shares of CVS Health from a "hold" rating to a "strong-buy" rating in a research note on Thursday, August 14th. Barclays boosted their target price on shares of CVS Health from $80.00 to $87.00 and gave the company an "overweight" rating in a research note on Thursday, September 4th. Weiss Ratings reissued a "hold (c-)" rating on shares of CVS Health in a research report on Saturday, September 27th. Finally, Wolfe Research raised their price objective on CVS Health from $80.00 to $85.00 and gave the stock an "outperform" rating in a research report on Monday, September 22nd. Two research analysts have rated the stock with a Strong Buy rating, nineteen have given a Buy rating and four have assigned a Hold rating to the company. Based on data from MarketBeat.com, the stock has an average rating of "Moderate Buy" and a consensus price target of $79.80.

CVS Health Trading Down 0.2%

Shares of NYSE:CVS opened at $76.78 on Friday. CVS Health Corporation has a 1 year low of $43.56 and a 1 year high of $79.20. The firm has a fifty day moving average price of $71.98 and a 200 day moving average price of $67.59. The stock has a market capitalization of $97.38 billion, a PE ratio of 21.45, a P/E/G ratio of 0.85 and a beta of 0.60. The company has a current ratio of 0.80, a quick ratio of 0.62 and a debt-to-equity ratio of 0.74.

CVS Health (NYSE:CVS - Get Free Report) last issued its quarterly earnings data on Thursday, July 31st. The pharmacy operator reported $1.81 earnings per share for the quarter, beating analysts' consensus estimates of $1.46 by $0.35. CVS Health had a return on equity of 10.51% and a net margin of 1.17%.The business had revenue of $98.92 billion for the quarter, compared to the consensus estimate of $94.87 billion. During the same period last year, the business earned $1.83 EPS. The firm's revenue was up 8.4% compared to the same quarter last year. CVS Health has set its FY 2025 guidance at 6.300-6.400 EPS. Analysts expect that CVS Health Corporation will post 5.89 EPS for the current fiscal year.

CVS Health Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Monday, November 3rd. Investors of record on Thursday, October 23rd will be given a dividend of $0.665 per share. This represents a $2.66 annualized dividend and a dividend yield of 3.5%. The ex-dividend date of this dividend is Thursday, October 23rd. CVS Health's payout ratio is currently 74.30%.

CVS Health Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.

Want to see what other hedge funds are holding CVS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CVS Health Corporation (NYSE:CVS - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.